Enovis Corporation/$ENOV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Enovis Corporation
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
- Ticker
- $ENOV
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 7,802
- Headquarters
- Wilmington, United States
- Website
- www.enovis.com
ENOV Metrics
BasicAdvanced
$1.4bn
-
-$19.22
-
-
Price and volume
Market cap
$1.4bn
52-week high
$34.28
52-week low
$19.14
Average daily volume
1.2m
Financial strength
Current ratio
1.985
Quick ratio
0.742
Long term debt to equity
88.312
Total debt to equity
90.84
Interest coverage (TTM)
0.81%
Profitability
EBITDA (TTM)
379.179
Gross margin (TTM)
61.31%
Net profit margin (TTM)
-47.97%
Operating margin (TTM)
3.63%
Effective tax rate (TTM)
-2.88%
Revenue per employee (TTM)
$290,000
Management effectiveness
Return on assets (TTM)
1.19%
Return on equity (TTM)
-54.14%
Valuation
Price to revenue (TTM)
0.616
Price to book
0.96
Price to tangible book (TTM)
-3.72
Price to free cash flow (TTM)
22.23
Free cash flow yield (TTM)
4.50%
Free cash flow per share (TTM)
1.111
Growth
Revenue change (TTM)
4.89%
Earnings per share change (TTM)
30.94%
3-year revenue growth (CAGR)
12.17%
10-year revenue growth (CAGR)
-4.49%
3-year earnings per share growth (CAGR)
95.79%
10-year earnings per share growth (CAGR)
20.39%
ENOV News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.